A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sampson, JH; Omuro, AMP; Preusser, M; Lim, M; Butowski, NA; Cloughesy, TF; Strauss, LC; Latek, RR; Paliwal, P; Weller, M; Reardon, DA

Published Date

  • May 20, 2016

Published In

Volume / Issue

  • 34 / 15_suppl

Start / End Page

  • TPS2079 - TPS2079

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2016.34.15_suppl.tps2079